InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Browse the full record of transactions filed by Simon Barry J., Director. Insider active across 1 companies, notably ImmunityBio, Inc.. Aggregated, 8 disclosures have been logged. Total volume traded: €2.8m. The latest transaction was disclosed on 24 February 2026 — Cession. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations8 total
US$763,77875,000 shares@ US$10.18370.0091% mcap51.7% of flow
Common Stock
SEC:0001647994-26-000006·
€763,77875,000 shares@ €10.18370.0091% mcap25.9% of flow
Common Stock
SEC:0001647994-26-000006:0·
US$432,47576,967 shares@ US$5.6190.0052% mcap29.3% of flow
Common Stock
SEC:0001647994-26-000002·
€432,47576,967 shares@ €5.6190.0052% mcap14.6% of flow
Common Stock
SEC:0001647994-26-000002:0·
€197,26514,990 shares@ €13.15970.0024% mcap13.4% of flow
Common Stock
SEC:0001209191-21-035815·
€197,26514,990 shares@ €13.15970.0024% mcap6.7% of flow
Common Stock
SEC:0001209191-21-035815:0·
€83,23056,967 shares@ €1.4610.0010% mcap5.6% of flow
Common Stock
SEC:0001209191-21-030886·
€83,23056,967 shares@ €1.4610.0010% mcap2.8% of flow
Common Stock
SEC:0001209191-21-030886:0·
8 of 8 declarations
About Simon Barry J.
Barry J. Simon is a Director at ImmunityBio, Inc. In this role, he participates in the governance of the company, contributing to strategic decision-making and oversight of operations. His expertise in the biopharmaceutical sector is valuable in guiding management and ensuring compliance with regulations. As a director, he plays a key role in developing the company's policies.
